Opening: US stocks opened slightly higher on Monday. This week the market focuses on Earnings Reports and economic data.

On the evening of April 28, Peking time, U.S. stocks opened slightly higher on Monday. Over 180 S&P component stocks, including Microsoft, Apple, Amazon, and Meta, will release their Earnings Reports this week. Important data such as non-farm employment and GDP will also be released this week. Investors continue to pay attention to the progress of trade negotiations. China has once again clarified that there are no negotiations or discussions on tariff issues between China and the U.S.

Global market report.Apr 28 09:30 ET

Morgan Stanley strategist Wilson: The weakness of the dollar will support US stocks outperforming Other global markets.

Michael Wilson of Morgan Stanley stated that a weaker dollar will support corporate earnings in the USA, helping American stocks outperform Other global markets. As many Wall Street strategists believe the era of American exceptionalism is coming to an end, Wilson uniquely believes that the USA remains a relatively good investment choice. He pointed out that the lower volatility of corporate earnings growth and the perception of higher quality among American companies are other reasons supporting this view. "We are still in the later stage of the cycle, where high-quality firms and large-cap stocks are expected to continue to perform well," he wrote in a report on Monday. Wilson expects

Global market broadcastApr 28 07:29 ET

Oppenheimer Adjusts Price Target on Bank of America to $51 From $50, Maintains Outperform Rating

MT NewswiresApr 28 07:10 ET · Ratings

Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts?

Moomoo News GlobalApr 28 06:10 ET

Bank of America Securities: Raised HANSOH PHARMA's Target Price to 29 Hong Kong dollars and reiterated a "Buy" rating.

Bank of America Securities released a Research Report stating that HANSOH PHARMA (03692) saw a 76.9% surge in sales of almonertinib in the first two months of this year, driving strong sales performance for the company. As a result, the revenue forecasts for 2025, 2026, and 2027 have been raised by 1.9%, 2.5%, and 2.7% respectively, and the Target Price has been increased from HKD 24.8 to HKD 29. Due to its robust R&D capabilities and the expansion of indications for existing major products, the rating is reiterated as "Buy."

Sina Hong Kong stocksApr 28 04:49 ET

Will the US Stock Market's Rebound Ignite Your Next Trade?

Moomoo News GlobalApr 28 04:46 ET